يعرض 1 - 10 نتائج من 32 نتيجة بحث عن '"Vali Papadimitrakopoulou"', وقت الاستعلام: 1.22s تنقيح النتائج
  1. 1
    Supplementary Table S1 from Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation In Vivo and In Vitro

    المؤلفون: Jeffrey N. Myers, Luka Milas, John Heymach, Vali Papadimitrakopoulou, Ehab Y. Hanna, Yoko Takahashi, David P. Molkentine, Mei Zhao, David R. Valdecanas, Fumihiko Matsumoto, Daisuke Sano

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3352db71678384add2b8986cb620184eTest
    https://doi.org/10.1158/1078-0432.22442255Test


    أضف إلى المفضلة
  2. 2
    Supplemenary Material from First-in-Human Phase I Dose-Escalation Study of the HSP90 Inhibitor AUY922 in Patients with Advanced Solid Tumors

    المؤلفون: Udai Banerji, Sandra Chica, Stuart Bailey, Hong Lu, Cristina Fernandez-Ibarra, Cornelia Quadt, Mikhail Akimov, Thomas A. Samuel, Tim Pluard, Vali Papadimitrakopoulou, Monica Mita, Karen S. Jacks, Carolyn Britten, Kapil N. Bhalla, Geoffrey I. Shapiro, Cristiana Sessa

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69893ece9f0acb07d6fba1fbddd37de0Test
    https://doi.org/10.1158/1078-0432.22451856Test


    أضف إلى المفضلة
  3. 3
    Data from First-in-Human Phase I Dose-Escalation Study of the HSP90 Inhibitor AUY922 in Patients with Advanced Solid Tumors

    المؤلفون: Udai Banerji, Sandra Chica, Stuart Bailey, Hong Lu, Cristina Fernandez-Ibarra, Cornelia Quadt, Mikhail Akimov, Thomas A. Samuel, Tim Pluard, Vali Papadimitrakopoulou, Monica Mita, Karen S. Jacks, Carolyn Britten, Kapil N. Bhalla, Geoffrey I. Shapiro, Cristiana Sessa

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a034f6fc317980ab615209f16ae4ac28Test
    https://doi.org/10.1158/1078-0432.c.6522309Test


    أضف إلى المفضلة
  4. 4
    Data from Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation In Vivo and In Vitro

    المؤلفون: Jeffrey N. Myers, Luka Milas, John Heymach, Vali Papadimitrakopoulou, Ehab Y. Hanna, Yoko Takahashi, David P. Molkentine, Mei Zhao, David R. Valdecanas, Fumihiko Matsumoto, Daisuke Sano

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::875ab0ddcf692a1ec405a7d2c17e3a53Test
    https://doi.org/10.1158/1078-0432.c.6519044.v1Test


    أضف إلى المفضلة
  5. 5
    Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC

    المؤلفون: Neda Kalhor, Vali Papadimitrakopoulou, Don L. Gibbons, Luyang Yao, Melenda Jeter, Ferdinandos Skoulidis, John V. Heymach, Charles Lu, Daniel R. Gomez, Lauren Averett Byers, Jonathan M. Kurie, Joe Y. Chang, Frank V. Fossella, George R. Blumenschein, Mehmet Altan, Michael S. O'Reilly, Anne S. Tsao, Yan Lin, Brett W. Carter, Zhongxing Liao, Peter F. Thall, Steven H. Lin, George R. Simon

    المصدر: Journal of Thoracic Oncology. 15:248-257

    مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Durvalumab, Locally advanced, Phases of clinical research, Antibodies, Monoclonal, Humanized, Cancer recurrence, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Adverse effect, Pneumonitis, business.industry, Consolidation Chemotherapy, medicine.disease, 030104 developmental biology, 030220 oncology & carcinogenesis, Neoplasm Recurrence, Local, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd52a5faec63f5ca6d70835c88d9f806Test
    https://doi.org/10.1016/j.jtho.2019.10.024Test


    أضف إلى المفضلة
  6. 6
    Outcome analysis of Phase I trial patients with metastatic KRAS and/or TP53 mutant non-small cell lung cancer

    المؤلفون: Naiyi Shi, Funda Meric-Bernstam, David S. Hong, Zhijie Wang, Vali Papadimitrakopoulou, Aung Naing, John V. Heymach, Russell Broaddus, Charles Lu, Vivek Subbiah, Daniel D. Karp, Apostolia Maria Tsimberidou, Yudong Wang, Kenneth R. Hess, Baoen Shan, Filip Janku, Siqing Fu, Sarina Anne Piha-Paul

    المصدر: Oncotarget

    مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, endocrine system diseases, overall survival, STK11, medicine.disease_cause, Metastasis, 03 medical and health sciences, Phase I trial, 0302 clinical medicine, CDKN2A, Internal medicine, medicine, KRAS, Missense mutation, Epidermal growth factor receptor, TP53, Lung cancer, neoplasms, non-small cell lung cancer, biology, business.industry, medicine.disease, digestive system diseases, respiratory tract diseases, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, business, Carcinogenesis, Research Paper

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f5681a7e051d7060d100560a0c241b6Test
    http://europepmc.org/articles/PMC6161801Test


    أضف إلى المفضلة
  7. 7
    The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer

    المؤلفون: Roy S. Herbst, Roshan Sharma, Akiko Iwasaki, Jong Woo Lee, Justin J Choi, Kyung Jin Eoh, Vali Papadimitrakopoulou, Ja Seok Koo, Hee Sun Park, Edward Kaftan, Jenny Wu, Miguel F. Sanmamed, Yu Zhang, Lieping Chen

    المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 14(6)

    مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Lung Neoplasms, Pyridones, medicine.medical_treatment, Population, Programmed Cell Death 1 Receptor, Adenocarcinoma of Lung, Mice, Transgenic, Pyrimidinones, medicine.disease_cause, B7-H1 Antigen, Article, Targeted therapy, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, Mice, 0302 clinical medicine, Immune system, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocols, medicine, Animals, education, Lung cancer, Protein Kinase Inhibitors, Trametinib, Mice, Knockout, education.field_of_study, business.industry, MEK inhibitor, Myeloid-Derived Suppressor Cells, Drug Synergism, medicine.disease, MAP Kinase Kinase Kinases, Survival Analysis, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Myeloid-derived Suppressor Cell, Cancer research, Female, KRAS, Tumor Suppressor Protein p53, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::544bced2b0240f2f77981a018e386ce7Test
    https://pubmed.ncbi.nlm.nih.gov/30771521Test


    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy

    المؤلفون: Li Mao, Adel K. El-naggar, Vali Papadimitrakopoulou, Dong M. Shin, Hyung C. Shin, Youhong Fan, Xiao Zhou, Gary Clayman, J. Jack Lee, Jin Soo Lee, Walter N. Hittelman, Waun Ki Hong

    المساهمون: The Pennsylvania State University CiteSeerX Archives

    المصدر: http://jnci.oxfordjournals.org/content/90/20/1545.full.pdfTest.

    وصف الملف: application/pdf

    العلاقة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.524.4793Test; http://jnci.oxfordjournals.org/content/90/20/1545.full.pdfTest

    الإتاحة: http://jnci.oxfordjournals.org/content/90/20/1545.full.pdfTest

    View record in BASE

    أضف إلى المفضلة
  9. 9
    Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma

    المؤلفون: C. David Fuller, Beth M. Beadle, Juhee Song, David I. Rosenthal, Stephen Y. Lai, Vali Papadimitrakopoulou, G. Brandon Gunn, Ryan P. Goepfert, Jan S. Lewin, Merrill S. Kies, Adam S. Garden, Martha P. Barrow, Brian P. Hobbs, David L. Schwartz, Katherine A. Hutcheson

    المصدر: The Laryngoscope. 127:842-848

    مصطلحات موضوعية: medicine.medical_specialty, business.industry, Retrospective cohort study, Dysphagia, Surgery, Clinical trial, 03 medical and health sciences, 0302 clinical medicine, Otorhinolaryngology, Swallowing, 030220 oncology & carcinogenesis, Predictive value of tests, Internal medicine, medicine, Stage (cooking), medicine.symptom, 030223 otorhinolaryngology, business, MD Anderson Dysphagia Inventory, Survival rate

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::eb0cdb8fe957404fdafa4c5b452818ccTest
    https://doi.org/10.1002/lary.26153Test


    أضف إلى المفضلة
  10. 10
    Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology

    المؤلفون: Edward B. Garon, Mary O'Brien, Massimo Barberis, Paolo Antonio Ascierto, Cesare Gridelli, Filippo de Marinis, Francesca Casaluce, Assunta Sgambato, Enriqueta Felip, Vali Papadimitrakopoulou, Suresh Senan

    المساهمون: Radiation Oncology, CCA - Evaluation of Cancer Care

    المصدر: Gridelli, C, Ascierto, P A, Barberis, M C P, Felip, E, Garon, E B, O'brien, M, Senan, S, Casaluce, F, Sgambato, A, Papadimitrakopoulou, V & De Marinis, F 2016, ' Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology ', Expert Opinion on Biological Therapy, vol. 16, no. 12, pp. 1479-1489 . https://doi.org/10.1080/14712598.2016.1234602Test
    Expert Opinion on Biological Therapy, 16(12), 1479-1489. Taylor and Francis Ltd.

    مصطلحات موضوعية: Research Report, 0301 basic medicine, Oncology, medicine.medical_specialty, Internationality, Lung Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Clinical Biochemistry, Antineoplastic Agents, Pembrolizumab, Disease, 03 medical and health sciences, 0302 clinical medicine, Immune system, Antigen, Carcinoma, Non-Small-Cell Lung, Internal medicine, Drug Discovery, Humans, Medicine, CTLA-4 Antigen, Lung cancer, Pharmacology, Clinical Trials as Topic, business.industry, Antibodies, Monoclonal, Immunotherapy, Congresses as Topic, medicine.disease, Immune checkpoint, Nivolumab, 030104 developmental biology, Italy, 030220 oncology & carcinogenesis, Immunology, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3e7fab28e24b6f6b6bf5904594176e9Test
    https://doi.org/10.1080/14712598.2016.1234602Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث